ENTITY
Hisamitsu Pharmaceutical Co

Hisamitsu Pharmaceutical Co (4530 JP)

86
Analysis
Health Care • Japan
HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.
more
•14 Dec 2021 23:03

Hisamitsu Pharmaceutical (4530 JP): Focus Shifts to ADHD Treatment Patch and Other Upcoming Launches

While our bear case still holds good for the company, near-term focus is now shifting to new launches and upcoming approvals. Hisamitsu is expected...

Logo
433 Views
Share
•10 Oct 2021 22:30

Hisamitsu Pharmaceutical (4530 JP): Avoid as More Pain Ahead

Shares of Hisamitsu is trading near 52-week low. However, investors should avoid the stock ahead of its Q2 results announcement due to near-term...

Logo
447 Views
Share
bullish•SG Holdings
•07 Aug 2021 11:41

JPX Nikkei 400 Index Rebalance: Big Turnover, Big Impact & A Market Consultation

There are 41 adds and 40 deletes for the JPX NK 400 Index. One-way turnover is high at 8.16% and will result in a trade of JPY 468bn. There will be...

Logo
662 Views
Share
bearish•Fast Retailing
•21 Mar 2021 19:18

BOJ Buying to Focus on TOPIX ETFs: Big Headline, Smaller Impact

The BOJ will only buy ETFs linked to the TOPIX going forward. While this makes for a big headline, the impact on the stocks is much more muted....

Logo
601 Views
Share
bullish•Quantitative Analysis
•31 Oct 2018 10:14

Japan: The Demise of The "J Nifty-Fifty"?

THE J 'NIFTY-FIFTY' - In our insight posted on July 1st Japan: Most Overbought & Most Oversold - The Relative Price Score, we highlighted the...

Logo
658 Views
Share
x